For example, it reduces oxidative stress, reduces cell damage in alcoholic & nonalcoholic fatty liver disease, improves insulin resistance, and much more
Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia
and the hepatic region that shows a portal space (C, D)
Sekhar, Siripoom V
RRF-2.3.1-21-2022-00001 of the Recovery and Resilience Facility under the Hungarian National Recovery Fund budget and RRF-2.3.1-21 to the National Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, UVMB
CLINUVELs lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel and Australia as the worlds first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP)